Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Dr. Lori Henderson

Lori A. Henderson, Ph.D.

Branch Chief
Clinical Grants and Contracts Branch
NCI Division of Cancer Treatment and Diagnosis (DCTD) Cancer Therapy Evaluation Program (CTEP)
240-276-5930
|
hendersonlori@mail.nih.gov

Dr. Henderson heads CTEP’s Clinical Grants and Contracts Branch. She directs programmatic activities for CGCB’s portfolio of clinical trials and research programs and manages CGCB's hematology-oncology portfolio. Dr. Henderson also supports large research network initiatives and databases including BMT-CTN, CIBMTR, CCSS, and PDXNet 2.0. She leads the NCI Clinical Trials Stewardship Committee, which reviews and updates NCI's procedures and operations to ensure proper oversight and monitoring of NCI-funded awards with clinical trials.

Dr. Henderson joined NCI in 2011 as a program director in DCTD’s Cancer Imaging Program. She oversees NCI-funded clinical imaging trials focused on the diagnosis and treatment of a wide range of solid tumors. Before joining the government, she was a senior scientist and global project leader at Novozymes North America (Novo Nordisk). She obtained her Ph.D. in polymer science (chemistry-engineering majors) from the University of Massachusetts, Lowell. This laid the groundwork for her understanding of biomaterials and biological processes for health-related research at the molecular and cellular levels.

  • Updated:
Email